Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$4.5 - $8.96 $272,106 - $541,793
-60,468 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$7.08 - $8.88 $24,985 - $31,337
-3,529 Reduced 5.51%
60,468 $527,000
Q4 2021

Feb 07, 2022

BUY
$7.09 - $8.7 $453,738 - $556,773
63,997 New
63,997 $494,000

Others Institutions Holding BWAY

About Brainsway Ltd.


  • Ticker BWAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,519,200
  • Market Cap $175M
  • Description
  • Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...
More about BWAY
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.